Crossmark

Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial

Crossref DOI link: https://doi.org/10.1038/tp.2016.152

Published Online: 2016-08-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kosaka, H

Okamoto, Y

Munesue, T

Yamasue, H

Inohara, K

Fujioka, T

Anme, T

Orisaka, M

Ishitobi, M

Jung, M

Fujisawa, T X

Tanaka, S

Arai, S

Asano, M

Saito, D N

Sadato, N

Tomoda, A

Omori, M

Sato, M

Okazawa, H https://orcid.org/0000-0001-7046-3383
Higashida, H

Wada, Y
License Information

Text and Data Mining valid from 2016-08-23

Version of Record valid from 2016-08-23
More Information

Article History

Received: 22 February 2016

Revised: 22 June 2016

Accepted: 4 July 2016

First Online: 23 August 2016

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below